Table 5.
|
African-Americans |
Caucasians |
||||||||||
Males |
Females |
Males |
Females |
|||||||||
Age Group, y |
Eyes at Risk |
Incidence % (n) |
Surgery % (n) |
Eyes at Risk |
Incidence % (n) |
Surgery % (n) |
Eyes at Risk |
Incidence % (n) |
Surgery % (n) |
Eyes at Risk |
Incidence % (n) |
Surgery % (n) |
65–69 | 10 | 30.0 (3) | 0.0 (0) | 24 | 20.8 (5) | 0.0 (0) | 54 | 44.4 (24) | 5.6 (3) | 91 | 30.8 (28) | 6.6 (6) |
70–74 | 21 | 23.8 (5) | 9.5 (2) | 31 | 19.4 (6) | 6.5 (2) | 84 | 30.1 (26) | 5.9 (5) | 119 | 26.9 (32) | 5.9 (7) |
75–79 | 20 | 10.0 (2) | 5.0 (1) | 40 | 30.0 (12) | 0.0 (0) | 76 | 34.2 (26) | 10.5 (8) | 89 | 24.7 (22) | 9.0 (8) |
≥80 | 10 | 20.0 (2) | 20.0 (2) | 19 | 26.3 (5) | 10.5 (2) | 38 | 15.8 (6) | 7.9 (3) | 48 | 16.7 (8) | 12.5 (6) |
Total | 61 | 19.7 (12) | 8.2 (5) | 114 | 24.6 (28) | 3.5 (4) | 252 | 32.5 (82) | 7.4 (19) | 347 | 25.9 (90) | 7.8 (27) |
Overall by ethnicity | Eyes at risk 175 | Progression % (n) 22.9 (40) | Surgery % (n) 5.1 (9) | Eyes at risk 599 | Progression % (n) 28.7 (172) | Surgery % (n) 7.7 (46) |
Nuclear progression: An increase of at least 0.3 units in eyes between 2.0 and 3.7 at baseline.
Note: In all, 87 eyes with baseline nuclear grade >3.7 not included on the table had surgery between visit 1 and visit 2; 291 eyes with baseline nuclear grade >3.7 and grades available in round 2 not included.